Skip to main content

Hypertrophic Cardiomyopathy

  • Reference work entry
Encyclopedia of Molecular Mechanisms of Disease
  • 30 Accesses

Synonyms

HCM; Heart hypertrophy

Definition and Characteristics

Hypertrophic cardiomyopathy (HCM) is the most common hereditary cardiac condition and transmitted by autosomal dominant inheritance. It is characterized by unexplained thickening of the myocardium and is a frequent cause of sudden cardiac death in young individuals. However, the disease expression is very heterogeneous even among related individuals and penetrance is incomplete. Disease presentation may occur at any age. In general, no specific genotype-phenotype correlation is apparent [1,2].

Prevalence

The prevalence of HCM is about 0.2% and similar among different racial groups based on large population studies comprising more than 16,000 subjects [3].

Genes

HCM is primarily a disease of the cardiac sarcomere. Eight disease genes have been identified and mutation analyses of these genes in large cohorts of HCM patients have revealed a mutation in 50–60% of cases [4]. Recently mutations in genes encoding Z-disk proteins...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,099.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE et al. (2003) American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 24:1965–1991

    PubMed  Google Scholar 

  2. Mogensen J, Murphy RT, Kubo T, Bahl A, Moon JC, Klausen IC et al. (2004) Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. J Am Coll Cardiol 44:2315–2325

    PubMed  CAS  Google Scholar 

  3. Zou Y, Song L, Wang Z, Ma A, Liu T, Gu H et al. (2004) Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am J Med 116:14–18

    PubMed  Google Scholar 

  4. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C et al. (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107:2227–2232

    PubMed  Google Scholar 

  5. Bos JM, Poley RN, Ny M, Tester DJ, Xu X, Vatta M et al. (2006) Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol Genet Metab 88:78–85

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag GmbH Berlin Heidelberg

About this entry

Cite this entry

Mogensen, J. (2009). Hypertrophic Cardiomyopathy. In: Lang, F. (eds) Encyclopedia of Molecular Mechanisms of Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-29676-8_876

Download citation

Publish with us

Policies and ethics